We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Fluorescence Imaging a Game-Changer for Bedside Biofilm Detection

By HospiMedica International staff writers
Posted on 18 Oct 2024
Print article
Image: The MolecuLight i:X is a class II FDA-cleared POC imaging devices for real-time detection of elevated bacterial burden in wounds (Photo courtesy of MolecuLight)
Image: The MolecuLight i:X is a class II FDA-cleared POC imaging devices for real-time detection of elevated bacterial burden in wounds (Photo courtesy of MolecuLight)

Biofilm is critically associated with various pathophysiological mechanisms that complicate or completely prevent the healing process. Accurate detection of biofilm is frequently challenged by the requirement for specialized techniques, which makes it impractical for many clinical environments. Now, a pioneering study that compared different bedside methods for biofilm detection to enable immediate and effective therapeutic responses found that fluorescence imaging showed greater sensitivity than traditional methods.

This groundbreaking study conducted by MolecuLight (Toronto, ON, Canada) evaluated several promising bedside techniques, including clinical signs of biofilm (CSB), biofilm blotting, and fluorescence imaging, in comparison to advanced laboratory-based gold standard methods. MolecuLight designs and markets the MolecuLight I and DX wound imaging devices, which are the only class II FDA-cleared point-of-care imaging devices for the real-time detection of increased bacterial burden in wounds. These devices also provide precise digital wound measurements for comprehensive wound management, supported by robust clinical evidence.

The findings, published in the Diagnostics Journal, indicated a significant incidence of biofilm in chronic wounds (62.5%), underscoring its critical role in affecting wound healing outcomes. Fluorescence imaging greatly enhanced the sensitivity and accuracy of biofilm detection compared to CSB and blotting, providing clinicians with a more dependable tool for detecting biofilm. The ability of fluorescence imaging to alert clinicians to the presence of biofilm at the point of care is vital for improving therapeutic strategies. This latest study further reinforces MolecuLight's commitment to enhancing wound care through innovative technology and high-quality research.

"Fluorescence imaging demonstrated superior sensitivity (84%) compared to traditional methods of bedside biofilm detection," said Anil Amlani, CEO of MolecuLight Inc. "This underscores the transformative impact of our technology in managing a crucial issue affecting the outcomes of chronic wounds by providing clinicians with real-time, objective data that can significantly enhance patient outcomes."

Related Links:
MolecuLight

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Standing Sling
Sara Flex
New
Anterior Cervical Plate System
XTEND

Print article

Channels

Surgical Techniques

view channel
Image: In appropriate patients, cure rates for testicular cancer are excellent with open surgery (Photo courtesy of IU School of Medicine)

Traditional Open Surgery for Lymph Node Removal Remains Gold Standard for Testicular Cancer

Testicular cancer is significantly less common than breast or prostate cancer but remains the most prevalent solid tumor in males aged 15 to 35. For the right patients, the cure rates for this type of... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.